Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,956 | 1,172 | 98.7% |
| Education | $257.63 | 11 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,243 | 163 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,876 | 119 | $0 (2024) |
| ABBVIE INC. | $1,848 | 88 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,390 | 111 | $0 (2024) |
| Lilly USA, LLC | $1,313 | 68 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,138 | 92 | $0 (2024) |
| MAYNE PHARMA INC. | $1,133 | 97 | $0 (2021) |
| Janssen Biotech, Inc. | $1,095 | 42 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $954.62 | 57 | $0 (2024) |
| LEO Pharma Inc. | $926.59 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,121 | 162 | Janssen Biotech, Inc. ($455.02) |
| 2023 | $3,298 | 217 | Janssen Biotech, Inc. ($371.65) |
| 2022 | $3,121 | 191 | Sun Pharmaceutical Industries Inc. ($541.59) |
| 2021 | $2,166 | 160 | SUN PHARMACEUTICAL INDUSTRIES INC. ($382.94) |
| 2020 | $2,387 | 161 | MAYNE PHARMA INC. ($294.68) |
| 2019 | $2,777 | 200 | Mayne Pharma Inc. ($599.44) |
| 2018 | $1,640 | 83 | Galderma Laboratories, L.P. ($299.29) |
| 2017 | $703.09 | 9 | AbbVie, Inc. ($239.63) |
All Payment Transactions
1,183 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $74.98 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,621 | 3,076 | $301,463 | $121,598 |
| 2022 | 22 | 1,464 | 2,830 | $292,110 | $113,639 |
| 2021 | 21 | 1,351 | 2,663 | $240,366 | $113,487 |
| 2020 | 12 | 418 | 868 | $52,897 | $25,736 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 236 | $51,920 | $23,021 | 44.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 230 | 278 | $51,000 | $21,418 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 170 | $26,350 | $11,963 | 45.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 38 | 54 | $15,090 | $7,148 | 47.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 96 | 118 | $21,830 | $7,141 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 169 | 214 | $23,910 | $6,671 | 27.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 58 | 69 | $15,175 | $6,655 | 43.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $15,200 | $6,642 | 43.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 27 | 35 | $10,145 | $4,899 | 48.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 131 | 780 | $10,680 | $4,047 | 37.9% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 18 | 20 | $6,140 | $3,089 | 50.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 28 | $6,780 | $2,998 | 44.2% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 24 | 25 | $5,685 | $2,452 | 43.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 52 | 65 | $5,705 | $2,376 | 41.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 24 | 26 | $5,720 | $1,898 | 33.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 19 | 21 | $4,510 | $1,679 | 37.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 112 | 145 | $5,310 | $1,591 | 30.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 36 | $3,420 | $1,475 | 43.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $2,990 | $1,201 | 40.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 13 | 13 | $2,730 | $1,000 | 36.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 19 | 19 | $3,515 | $992.34 | 28.2% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 11 | 11 | $2,090 | $530.21 | 25.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 91 | 566 | $4,528 | $460.84 | 10.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 24 | 50 | $1,040 | $252.24 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 263 | $57,860 | $24,597 | 42.5% |
About Dr. William Tausend, MD
Dr. William Tausend, MD is a Dermatology healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134549140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Tausend, MD has received a total of $19,214 in payments from pharmaceutical and medical device companies, with $3,121 received in 2024. These payments were reported across 1,183 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($18,956).
As a Medicare-enrolled provider, Tausend has provided services to 4,854 Medicare beneficiaries, totaling 9,437 services with total Medicare billing of $374,460. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Pasadena, TX
- Active Since 04/17/2014
- Last Updated 07/02/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1134549140
Products in Payments
- COSENTYX (Biological) $1,615
- DUPIXENT (Biological) $1,204
- TALTZ (Drug) $1,200
- ILUMYA (Biological) $1,065
- DORYX (Drug) $976.60
- SKYRIZI (Biological) $916.98
- TREMFYA (Drug) $848.91
- VTAMA (Drug) $661.07
- EUCRISA (Drug) $634.08
- Humira (Biological) $597.31
- ADBRY (Biological) $568.78
- Sotyktu (Drug) $561.30
- Otezla (Drug) $464.14
- COSENTYX (Drug) $463.99
- EPIDUO FORTE (Drug) $453.40
- Cimzia (Drug) $430.34
- DUOBRII (Drug) $366.40
- ENSTILAR (Drug) $335.56
- Ilumya (Biological) $326.07
- JUBLIA (Drug) $325.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Pasadena
Sara Gaspard, M.d, M.D
Dermatology — Payments: $436,969
Christine Hunt, M.d, M.D
Dermatology — Payments: $58,864
Dr. Manuel Davila, Md, MD
Dermatology — Payments: $33,958
Dr. Ashkan Ghorbani, Md, MD
Dermatology — Payments: $27,488
Prof. Wendy Magee, M.d, M.D
Dermatology — Payments: $25,850
Dr. Mary Garman, Md, MD
Dermatology — Payments: $22,772